首页 | 本学科首页   官方微博 | 高级检索  
     


Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma
Authors:Han‐Lin Hsu MD  Jer‐Hwa Chang MD  MS  Kevin Sheng‐Po Yuan MD  MS  Alexander T. H. Wu PhD  Jyh‐Ming Chow MD  Chia‐Lun Chang MD  Shee‐Uan Chen MD  PhD  Szu‐Yuan Wu MD  MPH   PhD
Affiliation:1. Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;2. School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan;3. Department of Otorhinolaryngology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;4. PhD Program for Translational Medicine, Taipei Medical University, Taipei, Taiwan;5. Department of Hemato‐Oncology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;6. Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan;7. Department of Radiation Oncology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;8. Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Abstract:
Keywords:concurrent chemoradiotherapy (CCRT)  squamous cell carcinoma  surgery alone  thoracic esophageal cancer  trimodality therapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号